AdvanSix (ASIX) Competitors

Chemours (NYSE:CC) and AdvanSix (NYSE:ASIX) are both basic materials companies, but which is the superior business? We will contrast the two companies based on the strength of their earnings, dividends, analyst recommendations, media sentiment, profitability, risk, institutional ownership, community ranking and valuation.

Does the media favor CC or ASIX?

In the previous week, Chemours had 14 more articles in the media than AdvanSix. MarketBeat recorded 16 mentions for Chemours and 2 mentions for AdvanSix. AdvanSix's average media sentiment score of 1.07 beat Chemours' score of -0.44 indicating that AdvanSix is being referred to more favorably in the news media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Chemours	2 Very Positive mention(s)	0 Positive mention(s)	5 Neutral mention(s)	3 Negative mention(s)	0 Very Negative mention(s)	Neutral
AdvanSix	1 Very Positive mention(s)	0 Positive mention(s)	1 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive

Do institutionals & insiders hold more shares of CC or ASIX?

76.3% of Chemours shares are held by institutional investors. Comparatively, 86.4% of AdvanSix shares are held by institutional investors. 0.5% of Chemours shares are held by company insiders. Comparatively, 5.6% of AdvanSix shares are held by company insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a stock will outperform the market over the long term.

Is CC or ASIX more profitable?

AdvanSix has a net margin of 2.46% compared to Chemours' net margin of 1.34%. Chemours' return on equity of 29.48% beat AdvanSix's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Chemours	1.34%	29.48%	2.74%
AdvanSix	2.46%	5.59%	2.78%

Which has more risk and volatility, CC or ASIX?

Chemours has a beta of 1.83, meaning that its stock price is 83% more volatile than the S&P 500. Comparatively, AdvanSix has a beta of 1.76, meaning that its stock price is 76% more volatile than the S&P 500.

Do analysts rate CC or ASIX?

Chemours currently has a consensus target price of $23.75, suggesting a potential upside of 22.35%. AdvanSix has a consensus target price of $39.50, suggesting a potential upside of 25.23%. Given AdvanSix's stronger consensus rating and higher probable upside, analysts clearly believe AdvanSix is more favorable than Chemours.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Chemours	0 Sell rating(s)	5 Hold rating(s)	3 Buy rating(s)	0 Strong Buy rating(s)	2.38
AdvanSix	0 Sell rating(s)	0 Hold rating(s)	2 Buy rating(s)	0 Strong Buy rating(s)	3.00

Is CC or ASIX a better dividend stock?

Chemours pays an annual dividend of $1.00 per share and has a dividend yield of 5.2%. AdvanSix pays an annual dividend of $0.64 per share and has a dividend yield of 2.0%. Chemours pays out 200.0% of its earnings in the form of a dividend, suggesting it may not have sufficient earnings to cover its dividend payment in the future. AdvanSix pays out 45.4% of its earnings in the form of a dividend.

Does the MarketBeat Community believe in CC or ASIX?

Chemours received 381 more outperform votes than AdvanSix when rated by MarketBeat users. However, 65.28% of users gave AdvanSix an outperform vote while only 60.69% of users gave Chemours an outperform vote.

Company	Underperform	Outperform
Chemours	Outperform Votes 633 60.69%	Underperform Votes 410 39.31%
AdvanSix	Outperform Votes 252 65.28%	Underperform Votes 134 34.72%

Which has preferable earnings & valuation, CC or ASIX?

AdvanSix has lower revenue, but higher earnings than Chemours. AdvanSix is trading at a lower price-to-earnings ratio than Chemours, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Chemours	$6.03B	0.48	-$238M	$0.50	38.82
AdvanSix	$1.53B	0.55	$54.62M	$1.41	22.37

Summary

AdvanSix beats Chemours on 12 of the 20 factors compared between the two stocks.